STRENGTHENING EVIDENCE THROUGH HEALTH RESEARCH WHERE MOST PEOPLE ACCESS HEALTHCARE, RACGP joins consortium and calls for practice-based research network in primary health
With
Dr Michael Wright GP, President
The Royal Australian College of General Practitioners (RACGP) &
Associate Professor,
International Centre for Future Health Systems (ICFHS)
Australian Health Journal segment
Filmed in Sydney | March 2025
In February 2025, the Australian Government committed over $22 million for primary care research, including $5.2m awarded to Professor Michael Kidd, Director of the International Centre for Future Health Systems at UNSW and recently appointed Australia’s Chief Medical Officer, to lead the establishment of one of the largest research collaborations in Australia focused on improving primary care.
The Royal Australian College of GPs says a new national multidisciplinary consortium for primary care research is a positive step forward to improve patient care.
The RACGP is a member of the National Multidisciplinary Primary Care Research, Policy and Advocacy Consortium, which involves 100 primary care researchers from 20 universities from across the country.
RACGP President Dr Michael Wright said: “Every year more than 22 million Australians see a specialist GP for their essential health care, making general practice is the most accessed part of our health system.
“Yet research in general practice is vastly underrepresented and underfunded. General practice receives less than 2% of our national medical research funding.
“This new consortium is an important and exciting opportunity to design, test and innovate models of care to better meet the needs of patients across Australia, and I’m proud the RACGP is a member.
“The RACGP is calling for all political parties to commit to funding a national practice-based research network, like they have in Canada and the United Kingdom.
“These networks have proven to be immensely valuable overseas.
“We’re also calling for funding to test how multidisciplinary practice teams work at full scope in Australia, in order to improve access to care for patients.
“We know people get the best outcomes when their GP works together with their other specialists, and health professionals, and it’s especially valuable for people with chronic and complex illnesses.
Source: Highlights from RACGP media release
You Might also like
-
Research Australia Awards celebrate researchers in life-changing science and discovery
For more than two decades, the Research Australia Health & Medical Research Awards have recognised the individuals and teams transforming health outcomes across the country. Now in their 22nd year, these prestigious awards showcase the depth and breadth of Australia’s research and innovation community — from discovery and translation through to commercialisation.
-
Enriching experiences in nursing mentorship
Mentoring in nursing is crucial for the development of nurses and the advancement of the nursing profession. It provides a supportive environment for personal and professional growth, knowledge transfer, and leadership development.
Australian Health Journal met with two nurses both working in Queensland, one the mentor, the other, the mentee. Both get to appreciate the experiences mentorship gives them.
-
Understanding extracellular vesicles in cancer therapy research
Joy Wolfram is an Associate Professor at the Australian Institute for Bioengineering and Nanotechnology and the School of Chemical Engineering at the University of Queensland in Australia. Originally from Finland, she earned both her bachelor’s and master’s degrees in biology before transitioning to engineering with a PhD in nanotechnology completed in China. Wolfram has over a decade of experience working in hospitals in the United States before joining the University of Queensland.
Her research focuses on extracellular vesicles, which are crucial for cell communication both locally within tissues and over longer distances between organs. Her lab studies the roles of these vesicles in both health and disease, particularly in cancer. They investigate the harmful messages released by cancer cells that aid in tumour growth, specifically in breast cancer, while also exploring how to harness beneficial extracellular vesicles from healthy individuals as potential therapeutics.